Cargando…
Repurposing of Bromocriptine for Cancer Therapy
Bromocriptine is an ergot alkaloid and dopamine D(2) receptor agonist used to treat Parkinson’s disease, acromegaly, hyperprolactinemia, and galactorrhea, and more recently diabetes mellitus. The drug is also active against pituitary hormone-dependent tumors (prolactinomas and growth-hormone produci...
Autores principales: | Seo, Ean-Jeong, Sugimoto, Yoshikazu, Greten, Henry Johannes, Efferth, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187981/ https://www.ncbi.nlm.nih.gov/pubmed/30349477 http://dx.doi.org/10.3389/fphar.2018.01030 |
Ejemplares similares
-
Pharmacogenomic Characterization and Isobologram Analysis of the Combination of Ascorbic Acid and Curcumin—Two Main Metabolites of Curcuma longa—in Cancer Cells
por: Ooko, Edna, et al.
Publicado: (2017) -
Drug Repurposing of the Anthelmintic Niclosamide to Treat Multidrug-Resistant Leukemia
por: Hamdoun, Sami, et al.
Publicado: (2017) -
Oridonin Targets Multiple Drug-Resistant Tumor Cells as Determined by in Silico and in Vitro Analyses
por: Kadioglu, Onat, et al.
Publicado: (2018) -
Pharmacogenomics of Scopoletin in Tumor Cells
por: Seo, Ean-Jeong, et al.
Publicado: (2016) -
Molecular Determinants of Sensitivity or Resistance of Cancer Cells Toward Sanguinarine
por: Saeed, Mohamed E. M., et al.
Publicado: (2018)